These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1604042)

  • 41. Platelet vasopressin receptor in patients with chronic renal failure.
    Inaba K; Umeda Y; Yamane Y; Urakami M; Nagata T; Inada M
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1079-84. PubMed ID: 2533288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central vasopressin receptors are upregulated by deoxycorticosterone acetate.
    Swords BH; Wyss JM; Berecek KH
    Brain Res; 1991 Sep; 559(1):10-6. PubMed ID: 1838296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arginine vasopressin receptors in pig cerebral microvessels, cerebral cortex and hippocampus.
    Pearlmutter AF; Szkrybalo M; Kim Y; Harik SI
    Neurosci Lett; 1988 Apr; 87(1-2):121-6. PubMed ID: 3380331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxytocin receptors in rat kidney during development.
    Schmidt A; Jard S; Dreifuss JJ; Tribollet E
    Am J Physiol; 1990 Dec; 259(6 Pt 2):F872-81. PubMed ID: 2175561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup.
    Szot P; Myers KM; Swank M; Dorsa DM
    Peptides; 1989; 10(6):1231-7. PubMed ID: 2622802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Water retention after oral chlorpropamide is associated with an increase in renal papillary arginine vasopressin receptors.
    Hensen J; Haenelt M; Gross P
    Eur J Endocrinol; 1995 Apr; 132(4):459-64. PubMed ID: 7711884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopressin responses and receptors in the mesenteric vasculature of estrogen-treated rats.
    St-Louis J; Parent A; Larivière R; Schiffrin EL
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H885-9. PubMed ID: 3777197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system control of pituitary vasopressin receptors: evidence for involvement of multiple factors.
    Lutz-Bucher B; Kovacs K; Makara G; Stark E; Koch B
    Neuroendocrinology; 1986; 43(5):618-24. PubMed ID: 3018613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography.
    Brinton RE; Gee KW; Wamsley JK; Davis TP; Yamamura HI
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7248-52. PubMed ID: 6095279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rat renal cell monolayer culture: a sensitive method for investigating ADH and PTH actions on the kidney by determining adenosine 3' :5'-cyclic monophosphate.
    Hatano T; Ogawa K; Yamamoto M; Kanda K; Matsui N
    Endocrinol Jpn; 1985 Apr; 32(2):215-23. PubMed ID: 2412806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule.
    Muto S; Tabei K; Asano Y; Imai M
    Eur J Pharmacol; 1985 Aug; 114(3):393-7. PubMed ID: 4065204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and localization of 3H-arginine8-vasopressin binding to rat kidney and brain tissue.
    Dorsa DM; Majumdar LA; Petracca FM; Baskin DG; Cornett LE
    Peptides; 1983; 4(5):699-706. PubMed ID: 6140673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction between epidermal growth factor and arginine vasopressin in renal medullary membranes.
    Grant SL; Phillips PA; Gow CB
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):243-7. PubMed ID: 8076430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of rodent liver and kidney AVP receptors: pharmacologic evidence for species differences.
    Tahara A; Tsukada J; Ishii N; Tomura Y; Wada K; Kusayama T; Yatsu T; Uchida W; Tanaka A
    Regul Pept; 1999 Oct; 84(1-3):13-9. PubMed ID: 10535403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An antibody directed against a peptide encoded by RNA complementary to mRNA for vasopressin recognizes putative vasopressin receptors.
    Swords BH; Carr DJ; Blalock JE; Berecek KH
    Neuroendocrinology; 1990 Apr; 51(4):487-92. PubMed ID: 2140594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.
    Howl J; Ismail T; Strain AJ; Kirk CJ; Anderson D; Wheatley M
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):189-95. PubMed ID: 2039469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic treatment with vasopressin analogues alters affinity of vasopressin receptors in the septum and amygdala of the rat brain.
    Swank MW; Dorsa DM
    Brain Res; 1991 Mar; 544(2):342-4. PubMed ID: 1828186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure and concentration capacity of the kidneys in brattleboro rats under conditions of long-term vasopressin treatment.
    Ivanova LN; Lavrinenko VA; Babina AV; Khegay II
    Bull Exp Biol Med; 2008 Nov; 146(5):642-6. PubMed ID: 19526112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local control of Leydig cell arginine vasopressin receptor by naloxone.
    Tahri-Joutei A; Fillion C; Bedin M; Hugues JN; Pointis G
    Mol Cell Endocrinol; 1991 Aug; 79(1-3):R21-4. PubMed ID: 1936535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability assessment of arginine-vasopressin (AVP) using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Sawada S; Nishide T; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Jan; 23(1):87-96. PubMed ID: 10706418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.